Obesity Drug Trial Stopped, Diabetes Drug Gets Green Light

The FDA has issued a clinical hold on Amgen’s phase I trial of the experimental weight-loss drug AMG 513. In other news, Children’s Hospital Los Angeles has suspended the initiation of puberty blockers in transgender patients younger than 19 after an executive order from former President Trump. Defense Secretary Pete Hegseth has also directed the military to suspend the integration of new transgender recruits and to suspend medical treatment for troops with gender dysphoria.